Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Qualio Reviews & Ratings
    4.4 out of 5 stars 919 Ratings
    Company Website for Qualio
  • Rise Vision Reviews & Ratings
    4.7 out of 5 stars 1,540 Ratings
    Company Website for Rise Vision
  • LM-Kit.NET Reviews & Ratings
    4.8 out of 5 stars 29 Ratings
    Company Website for LM-Kit.NET
  • Curtain MonGuard Screen Watermark Reviews & Ratings
    4.4 out of 5 stars 7 Ratings
    Company Website for Curtain MonGuard Screen Watermark
  • Paligo Reviews & Ratings
    4.5 out of 5 stars 104 Ratings
    Company Website for Paligo
  • TelemetryOS Reviews & Ratings
    4.8 out of 5 stars 282 Ratings
    Company Website for TelemetryOS
  • CrankWheel Reviews & Ratings
    4.9 out of 5 stars 240 Ratings
    Company Website for CrankWheel
  • Vaiz Reviews & Ratings
    4.6 out of 5 stars 50 Ratings
    Company Website for Vaiz
  • TurboTenant Reviews & Ratings
    4.3 out of 5 stars 874 Ratings
    Company Website for TurboTenant
  • MobiPDF Reviews & Ratings
    4.6 out of 5 stars 8,085 Ratings
    Company Website for MobiPDF

What is Compier Literature Screening?

Compier Literature Screening is an AI-driven tool designed to assist pharmacovigilance professionals in enhancing the efficiency of their review processes for abstracts, full texts, and translated documents to extract relevant details regarding patients, authors, events, products, and safety information. This cutting-edge platform integrates effortlessly with a range of online biomedical databases, such as Medline, and empowers users to upload large volumes of literature from diverse sources like Embase, conference proceedings, and PDF journals. It performs automated checks to eliminate duplicate entries for each literature search and utilizes validated AI technologies for the automatic identification and annotation of critical information. Users can customize scalable literature screening workflows tailored to their specific requirements while adhering to global regulatory standards. The system further fosters collaboration with external vendors to obtain full texts and is equipped with capabilities for translation. Additionally, it integrates seamlessly with safety management systems like Oracle Argus Safety, facilitating the sharing of articles pertinent to Individual Case Safety Reports (ICSRs) and thereby bolstering thorough safety monitoring. By streamlining these processes, the platform ultimately aims to enhance both the accuracy and effectiveness of pharmacovigilance operations, providing a valuable resource for professionals in the field. Furthermore, its user-friendly interface ensures that even those with minimal technical expertise can navigate the system efficiently.

What is CoVigilAI?

CoVigilAI represents a state-of-the-art innovation in the realm of medical literature monitoring, harnessing the power of artificial intelligence and advanced data analytics to proactively detect and manage adverse drug reactions, ensuring patient safety and compliance with regulatory requirements in real-time. This platform facilitates the efficient tracking of scientific and medical literature by retrieving data from prominent global databases such as PubMed and Embase, and it offers customizable search options that improve the pharmacovigilance literature review process. Furthermore, it conducts thorough evaluations of scientific articles and publications from various regional journals, guaranteeing an extensive oversight of both global and localized literature. With the implementation of sophisticated algorithms, the system categorizes Individual Case Safety Reports (ICSRs) into three distinct classifications: valid, potential, and invalid cases, while its automated key entity recognition feature proficiently pinpoints critical components such as patients, medications, adverse reactions, and pertinent medical events. This comprehensive strategy not only streamlines the monitoring procedure but also considerably boosts the precision and efficiency of drug safety evaluations, contributing to a safer healthcare environment. Ultimately, CoVigilAI serves as an indispensable tool for enhancing drug safety and fostering informed decision-making in the medical field.

Media

Media

Integrations Supported

MEDLINE
Oracle Argus

Integrations Supported

Embase
PubMed

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
Online Training
On-Site Training

Training Options

Documentation Hub
Online Training
On-Site Training

Company Facts

Organization Name

Techsol Life Sciences

Date Founded

2010

Company Location

Techsol Life Sciences

Company Website

www.techsollifesciences.com/pharmacovigilance/compier-literature-screening/

Company Facts

Organization Name

CoVigilAI

Company Location

India

Company Website

covigilai.in/

Categories and Features

Pharmacovigilance

Not specified

Categories and Features

AI Science

Not specified

Pharmacovigilance

Not specified

Popular Alternatives

Dialog Reviews & Ratings

Dialog

Clarivate

Popular Alternatives

Dialog Reviews & Ratings

Dialog

Clarivate